Bicycle Therapeutics plcBCYCNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+56.8%
5Y CAGR+40.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+56.8%/yr
vs +39.5%/yr prior
5Y CAGR
+40.5%/yr
Recent acceleration
Acceleration
+17.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.5x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $172.97M | +10.5% |
| 2023 | $156.50M | +91.8% |
| 2022 | $81.61M | +81.8% |
| 2021 | $44.88M | +35.4% |
| 2020 | $33.15M | +4.8% |
| 2019 | $31.64M | +52.4% |
| 2018 | $20.76M | +75.0% |
| 2017 | $11.87M | +21.4% |
| 2016 | $9.77M | - |